Company Short-Term Debts: AIM ImmunoTech (AIM)
The market trend for AIM ImmunoTech (AIM) shares reflects the impact of management restructuring and a shift in commercial strategy following shareholder pressure, while the separate_debt_short metric stands at 0.01. The business relies on exclusive Ampligen patents, which create barriers for competitors under strict FDA oversight. The lack of comparable immunomodulators allows AIM ImmunoTech (AIM) to exercise significant pricing power regarding the cost of oncology therapies.
AIM ImmunoTech, Inc. - analytical breakdowns and key metrics (AIM)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Initial company analysis:AIM ImmunoTech Inc. (AIM)
This indicator aggregates all obligations with maturities of up to twelve months, allowing investors to assess the current liquidity and transparency of the business's debt load. The dynamics of short-term financial debt are critical for AIM ImmunoTech, as controlling short-term payments ensures sustainable funding for Ampligen's multidisciplinary clinical trials, minimizing risks while diversifying oncology and virus therapy programs.
Competitor analysis for AIM ImmunoTech
ARGX: Company Short-Term Debt|BNTX - Company Current Liabilities|ABVX: Company Short-Term Debts|Company Short-Term Debts ADMA Corp|PTGX - Company Current Liabilities|Company Short-Term Loans and Borrowings immunovant.com|KNSA (Kiniksa) - Company Short-Term Debts|Short-Term Debt Volume GRFS (Grifols SA)|Adaptive Biotechnologies Corp - Company Short-Term Debt|Celldex Corp - Company Current Liabilities|AUPH: Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debt Pharvaris Corp (PHVS)|Company Short-Term Indebtedness abcellera.com|Tourmaline Bio, Inc. - Company Short-Term Debts|Short-Term Debt precigen.com (PGEN)|Company Short-Term Debts PHAR (Pharming Group)|Company Short-Term Debts Nektar Therapeutics Inc NKTR|Company Short-Term Debts UPB (Upstream Bio Corp)|ZBIO: Short-Term Debt Volume|IMNM (Immunome, Inc.) - Company Short-Term Debt|Company Current Liabilities gossamerbio.com|KALV - Company Current Liabilities|Company Short-Term Loans and Borrowings Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Company Short-Term Debts|Short-Term Debt Volume SVRA (Savara Pharma)|Rigel Pharmaceuticals - Company Short-Term Debt|anaptysbio.com - Company Current Liabilities|ATXS: Company Short-Term Debt|enGene Holdings Inc (ENGN) - Company Current Liabilities|RAPT: Company Current Liabilities|JBIO (Aerovate Therapeutics) - Company Short-Term Debts|Company Short-Term Debt Aclaris Therapeutics (ACRS)|Company Short-Term Indebtedness KYTX|Tiziana Life Sciences Ltd - Company Short-Term Debt|Short-Term Debt Cabaletta Bio Inc. CABA|Company Current Liabilities Ventyx Bio (VTYX)|Amount of Current Liabilities Theratechnologies, Inc THTX|AVTX (Avalo Therapeutics, Inc) - Company Short-Term Debts|ELDN - Short-Term Debt|AGEN (Agenus Inc.) - Company Short-Term Debts|Climb Bio Inc. (CLYM) - Company Current Liabilities|ZURA - Company Short-Term Debts|Company Short-Term Loans and Borrowings aTyr Pharmaceuticals|Company Short-Term Debts ADAG|Company Short-Term Debts ikenaoncology.com (IMA)|Company Short-Term Debts STTK|Equillium Inc - Short-Term Debt Volume|CNTB: Company Short-Term Debt|IMUX: Company Current Liabilities|Company Short-Term Debt atarabio.com (ATRA)|InflaRx (IFRX) - Current Liabilities|XFOR - Company Short-Term Debts|Company Short-Term Loans and Borrowings Adicet|Company Short-Term Debts CELU|Company Short-Term Debts INMB (INmune Bio Corporation)|Company Short-Term Debt Barinthus Biotherapeutics|kezarlifesciences.com - Company Short-Term Loans and Borrowings|SABS: Company Short-Term Debt|AKTX - Company Current Liabilities|ENLV: Company Short-Term Debts|Company Short-Term Debts Q32 Bio|GOVX - Company Current Liabilities|Company Short-Term Loans and Borrowings edesabiotech.com|IBIO (iBio) - Company Short-Term Debts|Short-Term Debt Volume CARM (carismatx.com)|XTL Biopharmaceuticals, Ltd. - Company Short-Term Debt|Bolt Biotherapeutics Inc. - Company Current Liabilities|HCWB: Company Short-Term Debt|Aptevo Therapeutics (APVO) - Company Current Liabilities|ADTX: Company Current Liabilities|GRI (GRI Bio Inc) - Company Short-Term Debts|Company Short-Term Debt XORTX (XRTX)|Company Short-Term Indebtedness Vyome Therapeutics|Revelation Biosciences - Company Short-Term Debts|Short-Term Debt indaptusrx.com (INDP)|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|Company Short-Term Debts AFMD (Affimed Therapeutics)|ALLK: Short-Term Debt Volume|HOOK (hookipapharma.com) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|ITOS - Company Current Liabilities|Company Short-Term Loans and Borrowings Ocean Biomedical Inc|TCBP (TC BioPharm (Holdings) PLC) - Company Short-Term Debts|Short-Term Debt Volume THRD (Third Harmonic Bio Inc)